Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Current Osteoporosis Reports|September 19, 2018
Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular DystrophyAntoine Boulanger Piette, Dounia Hamoudi, Laetitia Marcadet, et al.
Human Molecular Genetics|June 11, 2019
An anti-RANKL treatment reduces muscle inflammation and dysfunction and strengthens bone in dystrophic miceDounia Hamoudi, Laetitia Marcadet, Antoine Piette Boulanger, et al.
Human Molecular Genetics|January 17, 2020
Muscle weakness and selective muscle atrophy in osteoprotegerin-deficient miceDounia Hamoudi, Zineb Bouredji, Laetitia Marcadet, et al.
Bioconjugate Chemistry|September 23, 2008
Selectins ligand decorated drug carriers for activated endothelial cell targetingXavier Banquy, Grégoire Leclair, Jean-Michel Rabanel, et al.
The American Journal of Pathology|May 12, 2026
Anti-RANKL improves muscle dysfunction and strengthens bone in laminin-α2-deficient dy2J/dy2J dystrophic miceZineb Bouredji, Anthony Facchin, Dounia Hamoudi, et al.
Plos One|August 17, 2013
Cannabinoid receptor CB2 modulates axon guidanceGabriel Duff, Anteneh Argaw, Bruno Cecyre, et al.
Journal of Huntington'S Disease|October 28, 2025
Morphological and functional phenotyping of skeletal muscle and bone in the zQ175 knock-in mouse model of Huntington's diseaseBehnaz Nateghi, Mohamed Lala Bouali, Zineb Bouredji, et al.
Eneuro|January 6, 2016
Role of GPR55 during Axon Growth and Target InnervationHosni Cherif, Anteneh Argaw, Bruno Cécyre, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 29, 2011
Concerted action of CB1 cannabinoid receptor and deleted in colorectal cancer in axon guidanceAnteneh Argaw, Gabriel Duff, Nawal Zabouri, et al.
Pageof 3